Evidence map›Paper›PMID 29370822›Full record

SynthesisAlzheimer's research & therapy2018

Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review.

Emil Ygland, Danielle van Westen, Elisabet Englund, Rosa Rademakers, Zbigniew K Wszolek, Karin Nilsson, Christer Nilsson, Maria Landqvist Waldö, Irina Alafuzoff, Oskar Hansson and 2 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Alzheimer's research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Tau filaments with the Alzheimer fold in cases withbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. A novelFrontiers in neurology · 2024
    Article
  7. Article
  8. Review
  9. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.Brain : a journal of neurology · 2022
    Article
  10. Review
  11. Review
  12. MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology.Annals of clinical and translational neurology · 2021
    Article
  13. Tau and MAPT genetics in tauopathies and synucleinopathies.Parkinsonism & related disorders · 2021
    Review
  14. New MAPT variant in a FTD patient with Alzheimer's disease phenotype at onset.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  15. Article
  16. Review
  17. Brain volumetric deficits in MAPT mutation carriers: a multisite study.Annals of clinical and translational neurology · 2021
    Article
  18. Genetics of Progressive Supranuclear Palsy: A Review.Journal of Parkinson's disease · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Emil YglandLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Getingevägen 4, 221 85, Lund, Sweden.
Danielle van WestenLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Diagnostic Radiology, Getingevägen 4, 221 85, Lund, Sweden.
Elisabet EnglundLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Oncology and Pathology, Sölvegatan 23, 221 85, Lund, Sweden.
Rosa RademakersDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Zbigniew K WszolekDepartment of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Karin NilssonLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Getingevägen 4, 221 85, Lund, Sweden.
Christer NilssonLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Getingevägen 4, 221 85, Lund, Sweden.
Maria Landqvist WaldöLund University, Skåne University Hospital/Ängelholm Hospital, Department of Clinical Sciences Lund, Memory Clinic, Västersjögatan 10, 262 82, Ängelholm, Sweden.
Irina AlafuzoffDepartment of Immunology, Genetics and Pathology, Clinical and Experimental Pathology, Uppsala University, Rudbecklaboratoriet, 75185, Uppsala, Sweden.
Oskar HanssonLund University, Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund, Sweden.
Lars GustafsonLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Getingevägen 4, 221 85, Lund, Sweden.
Andreas PuschmannLund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Getingevägen 4, 221 85, Lund, Sweden. andreas.puschmann@med.lu.se.
Lund University · SESkåne University Hospital · SEMayo Clinic in Florida · USUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe MAPT c.1216C > T (p.Arg406Trp; R406W) mutation is a known cause of frontotemporal dementia with Parkinsonism linked to chromosome 17 tau with Alzheimer's disease-like clinical features.

methodsWe compiled clinical data from a new Swedish kindred with R406W mutation. Seven family members were followed longitudinally for up to 22 years. Radiological examinations were performed in six family members and neuropathological examinations in three. We systematically reviewed the literature and compiled clinical, radiological, and neuropathological data on 63 previously described R406W heterozygotes and 3 homozygotes.

resultsFor all cases combined, the median age of onset was 56 years and the median disease duration was 13 years. Memory impairment was the most frequent symptom, behavioral disturbance and language impairment were less common, and Parkinsonism was rare. Disease progression was most often slow. The most frequent clinical diagnosis was Alzheimer's disease. R406W homozygotes had an earlier age at onset and a higher frequency of behavioral symptoms and Parkinsonism than heterozygotes. In the new Swedish kindred, a consistent imaging finding was ventromedial temporal lobe atrophy, which was evident also in early disease stages as a widening of the collateral sulcus with ensuing atrophy of the parahippocampal gyrus. Unlike previously published R406W carriers, all three autopsied patients from the novel family showed neuropathological similarities with progressive supranuclear palsy, with predominant four-repeat (exon 10+) tau isoform (4R) tauopathy and neurofibrillary tangles accentuated in the basal-medial temporal lobe. Amyloid-β pathology was absent.

conclusionsDominance of 4R over three-repeat (exon 10-) tau isoforms contrasts with earlier reports of R406W patients and was not sufficiently explained by the presence of H1/H2 haplotypes in two of the autopsied patients. R406W patients often show a long course of disease with marked memory deficits. Both our neuropathological results and our imaging findings revealed that the ventromedial temporal lobes were extensively affected in the disease. We suggest that this area may represent the point of origin of tau deposition in this disease with relatively isolated tauopathy.

Indexed as

MutationAgedAge of OnsetBrainDementiaDisease ProgressionFamilyFemaleHumansLongitudinal StudiesMaleMiddle Agedtau ProteinsMAPT protein, humantau Proteins

Identifiers

PMID29370822
PMCPMC6389050
OpenAlexW2794613172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.